IMPLICATIONS OF PHYSICAL, BEHAVIORAL, AND PSYCHOSOCIAL IMPACTS OF HEAD AND NECK CANCER

Synopsis
This talk will explore the financial challenges faced by cancer survivors, particularly the financial toxicity stemming from oral complications resulting from head and neck cancer therapy. Cancer survivors often experience ongoing out-of-pocket expenses, and reduced access to healthcare resources, leading to significant financial burdens even years after their initial diagnosis. Participants will delve into the specifics of how these factors intersect and contribute to the broader issue of financial toxicity in the context of head and neck cancer care.

Learning Objectives

1. To increase awareness among oral medicine or actinides about the financial challenges and long-term financial toxicity associated with managing oral complications resulting from head and neck cancer therapy.
2. To understand the specific financial burdens faced by patients with oral complications, including out-of-pocket costs, employment limitations, and reduced access to healthcare resources.
3. To explore potential strategies and resources available to mitigate the financial toxicity of head and neck cancer treatment.

Speaker
Alessandro Villa, DDS, PhD, MPH

IMPLICATIONS OF PHYSICAL, BEHAVIORAL, AND PSYCHOSOCIAL IMPACTS OF HEAD AND NECK CANCER

Synopsis
TBD

Learning Objectives

1. Discuss potential mechanisms, manifestations and impact of systemic symptoms associated with head and neck cancer and cancer treatment.
2. Discuss behavioral changes manifested after head and neck cancer therapy and the potential impact.
3. Review the challenges of measuring systemic symptoms and the need for development of objective measures of impaired function.

Speaker
Barbara A. Murphy, MD

IMPLICATIONS OF PHYSICAL, BEHAVIORAL, AND PSYCHOSOCIAL IMPACTS OF HEAD AND NECK CANCER

Synopsis
With the current transition to electronic health records, the utilization of “Real-world data” has opened endless opportunities in making informed clinical decisions. This talk will shed light on the current paradigm of using “Real-world Data” for prediction and evaluation of outcomes in head and neck cancer, as well as advancement of informed patient care.

Learning Objectives

1. To discuss and define Real World Data, Big Data, and Artificial Intelligence in general and pros and cons of each.
2. To provide specific examples of how RWD and Big Data have been applied to predict and assess outcomes in H/N cancer.
3. To discuss the potential opportunities for the application of AI to H/N cancer outcomes.

Speaker
Stephen T. Sonis, DMD, DMSc

SAMUEL CHARLES MILLER LECTURE

Synopsis
This lecture is based on the published works of Dr. Charles Greene and several colleagues in the past 6 years. Beginning with a new perspective on TMJ functional anatomy, the topic of clinical vs technological approaches to diagnosis of TMDs is discussed. Next, the topic of “overtreatment success” is considered in terms of its negative impact on the practitioner, the patient, and the profession. Last, the subject of what constitutes appropriate treatment for TMDs in the 21st century is contrasted with the historical approaches to that issue. Following the discussion of these 4 pillars, a recent overview paper is briefly reviewed to give the audience a state-of-the-art summary of contemporary thinking in the expert TMD community.

Learning Objectives - At the conclusion of this presentation, the audience will have:

1. A modern understanding of how the human TMJ develops and functions.
2. An appreciation for the distinction between clinical vs technological diagnostic approaches to orofacial pain patients.
3. A realization that treatment success cannot be the barometer for determining whether various TMD treatment approaches are appropriate.
4. An understanding of how treatment concepts have evolved from the past century to the current period.

Speaker
Charles Greene, DDS

Synopsis
The diagnosis and treatment of craniofacial pain disorders can be clinically challenging given the overlap between different diagnoses and the presence of co-existing disorders that can complicate management. Once the correct diagnosis has been established, a multimodal approach with pharmacotherapy, physical therapy, and injectable/interventional modalities tends to yield the best results. In treatment-refractory cases, surgical interventions could be considered once the best medical management has provided inadequate results.

Learning Objectives

1. To accurately diagnose trigeminal neuralgia and other causes of craniofacial pain.
2. To select the optimal pharmacological and interventional techniques for the management of craniofacial pain disorders.
3. To select the optimal surgical techniques for the treatment of craniofacial pain disorders.

Speaker
Paul Mathew, MD, DNBPAS, FAAN, FAHS

Synopsis
Topical therapies play a pivotal role in managing orofacial pain, offering targeted relief for various pain conditions. This talk will explore the pharmacology, selection criteria, application techniques, and indications of topical agents, empowering clinicians to offer precise relief for orofacial pain. With their ability to minimize systemic side effects and improve patient comfort, topical therapies offer a valuable addition to the armamentarium of pain management strategies.

Learning Objectives

1. To recognize the importance of topical therapies in managing orofacial pain.
2. To describe the pharmacological mechanisms of topical therapies and evaluate selection criteria for appropriate topical agents based on the type and severity of orofacial pain.
3. To identify the specific orofacial pain conditions that warrant the use of topical therapies.

Speaker
Gary Heir, DMD

Session Times

• Session #1 - 5:00PM - 5:25PM
• Session #2 - 5:30PM - 5:55PM
• Session #3 - 6:00PM - 6:25PM